Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Talbot

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The New Zealand Medical Journal|September 26, 1984
Rheumatic fever and rheumatic heart disease in the Hamilton health district: II. Long term follow-up and secondary prophylaxisR G Talbot
The New Zealand Medical Journal|June 8, 1988
Rheumatic fever in the Hamilton health district: a nine year prospective studyR G Talbot
American Heart Journal|April 1, 1975
MexiletineR G Talbot
The New Zealand Medical Journal|September 26, 1984
Rheumatic fever and rheumatic heart disease in the Hamilton health district: I. An epidemiological surveyR G Talbot
American Heart Journal|January 1, 1976
Long-term treatment of ventricular arrhythmias with oral mexiletineR G Talbot, D G Julian, L F Prescott
British Medical Journal|April 17, 1976
Impaired Lignocaine metabolism in patients with myocardial infarction and cardiac failureL F Prescott, K K Adjepon-Yamoah, R G Talbot
Postgraduate Medical Journal|January 1, 1977
Long term treatment of ventricular arrhythmias with oral mexiletineR W Campbell, D G Julian, R G Talbot, et al.
British Heart Journal|July 1, 1975
Proceedings: Comparison of mexiletine and procainamide in prevention of recurrent ventricular arrhythmias after acute myocardial infarctionR W Campbell, R G Talbot, M Dolder, et al.
British Heart Journal|May 1, 1973
Ko 1173--an effective new antiarrhythmic drugR A Clark, R G Talbot, J Nimmo, et al.
Advances in Clinical Pharmacology|January 1, 1978
[Treatment of ventricular arrhythmias after acute myocardial infarct with procaine amide and mexiletine]M Dolder, R W Campbell, R G Talbot, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The New Zealand Medical Journal|September 26, 1984
Rheumatic fever and rheumatic heart disease in the Hamilton health district: II. Long term follow-up and secondary prophylaxisR G Talbot
The New Zealand Medical Journal|June 8, 1988
Rheumatic fever in the Hamilton health district: a nine year prospective studyR G Talbot
American Heart Journal|April 1, 1975
MexiletineR G Talbot
The New Zealand Medical Journal|September 26, 1984
Rheumatic fever and rheumatic heart disease in the Hamilton health district: I. An epidemiological surveyR G Talbot
American Heart Journal|January 1, 1976
Long-term treatment of ventricular arrhythmias with oral mexiletineR G Talbot, D G Julian, L F Prescott
British Medical Journal|April 17, 1976
Impaired Lignocaine metabolism in patients with myocardial infarction and cardiac failureL F Prescott, K K Adjepon-Yamoah, R G Talbot
Postgraduate Medical Journal|January 1, 1977
Long term treatment of ventricular arrhythmias with oral mexiletineR W Campbell, D G Julian, R G Talbot, et al.
British Heart Journal|July 1, 1975
Proceedings: Comparison of mexiletine and procainamide in prevention of recurrent ventricular arrhythmias after acute myocardial infarctionR W Campbell, R G Talbot, M Dolder, et al.
British Heart Journal|May 1, 1973
Ko 1173--an effective new antiarrhythmic drugR A Clark, R G Talbot, J Nimmo, et al.
Advances in Clinical Pharmacology|January 1, 1978
[Treatment of ventricular arrhythmias after acute myocardial infarct with procaine amide and mexiletine]M Dolder, R W Campbell, R G Talbot, et al.
Pageof 2